HOME >> BIOLOGY >> NEWS
Fe-TAML(R) activators developed at Carnegie Mellon remove recalcitrant sulfur from automotive fuels

NEW YORK--More than 85 percent of recalcitrant sulfur compounds in refined automotive fuels can be easily removed using a powerful, environmentally friendly catalyst developed by Carnegie Mellon University scientists.

With further development this technology, which employs a Fe-TAML activator, may provide an attractive alternative to existing methods that rid fuels of sulfur contaminants, which are associated with serious human health problems and contribute to acid rain. These same contaminants also cause engines to burn fuel less efficiently.

Results of this laboratory research will be presented by Colin Horwitz, research associate professor at Carnegie Mellon, on Wednesday, Sept. 10, at the 226th annual meeting of the American Chemical Society (paper 160, "Oxidation of sulfur compounds in fuels using Fe-TAML activators and hydrogen peroxide," Industrial and Engineering Chemistry Division). This research was funded by the Department of Energy.

"We are working to develop Fe-TAML activators to clean fuels to the point where they will comply with stringent EPA sulfur standards slated to go into effect by 2006," said Horwitz. "This technology could aid significantly in the development of cleaner burning, more fuel-efficient automobile engines."

Most diesel fuels on the market in the United States contain 500 parts per million (ppm) of sulfur contaminants. By approximately 2010, the EPA will require all transportation fuels to contain no more than 30 ppm of these pollutants. Sulfur contaminants interfere with other technologies designed to prevent release of soot particles. As a result, these particles are released into exhaust fumes, along with sulfur contaminants (sulfur oxides). The particles have been linked to asthma, while sulfur oxides contribute to acid rain.

Fe-TAMLs (TAML stands for tetra-amido macrocyclic ligand) are synthetic catalysts made with elements found in nature.

When Fe-TAMLs and hydrogen peroxide ar
'"/>

Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
10-Sep-2003


Page: 1 2

Related biology news :

1. Fe-TAML(R) activators developed at Carnegie Mellon decontaminate anthrax simulant
2. Fe-TAML(R) activators developed at Carnegie Mellon break down toxic pesticides
3. Fe-TAML(R) activators developed at Carnegie Mellon help cleanup paper and wood pulp manufacturing
4. Fe-TAML(R) activators developed at Carnegie Mellon decolorize textile mill wastewater
5. Computer database being developed at Temple will allow for better inventory of chemicals
6. New software developed at Rensselaer predicts promising ingredients for new drugs
7. New imaging technique developed to identify breast cancer
8. Portable kidney dialysis machine developed
9. New method of identifying and isolating stem cells developed
10. Study calls for cheaper antitoxins for plant poisoning in less-developed countries
11. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... MANSFIELD, Mass. (PRWEB) , ... June 24, 2020 ... ... provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug ... trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. ...
(Date:6/23/2020)... ... June 23, 2020 , ... First ... Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable energy equipment, ... in the fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s ...
(Date:6/23/2020)... THE WOODLNDS, Texas (PRWEB) , ... June 23, ... ... in X-ray analytical instrumentation, is pleased to announce the next event in a ... of X-ray scattering. , The TOPIQ series of webinars was developed in response ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, the ... is only the beginning of a successful study, while protecting and accessing the catheter ... Global Head of Surgery from Envigo in a live webinar ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
Breaking Biology Technology:
Cached News: